1、JUNE202 5The Global Use of Medicines Outlook through 2029Increasing Access,Use,and SpendingIncreasing availability and usage of medicines,and the associated amount being spent,have become central issues in health policy and international trade discussions in recent years,including the potential resh

2、aping of global markets and drug pricing that is being proposed by the new U.S.administration.Breakthrough therapies launched over the past decade for multiple diseases are reshaping patient care in many areas,while established patterns of spending and usage continue to highlight differences in acce

3、ss and pricing across countries.The largest driver of medicine spending growth through the next five years is still expected to be the availability and use in developed markets of innovative therapeutics and offset by losses of exclusivity and the lower costs of generics and biosimilars.Traditionall

4、y,growth in the use of innovative medicine has occurred mostly in the years immediately following launch,whereas in recent years and in the forecast outlook,growth is driven by older products.This mix of spending growth between volume-driven growth and mix-driven changes in the cost of therapy are s

5、howing most geographies shifting to more expensive therapies,reflecting the broader availability and patient access to medicines with higher clinical value.In this report,we quantify the impact of these dynamics and examine the spending and usage of medicines in 2024 and the outlook to 2029,globally

6、 and for specific therapy areas and countries or regions.We intend for this report to provide an evidence-based foundation for meaningful discussion by all stakeholders around the value,cost,and role of medicines over the next five years in the context of overall healthcare spending.The study was pr